JOHNSON & JOHNSON — Director's Dealing 2016

Jun 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2016-06-07

Reporting Person: Pruden Gary J (Exec VP, WW Chair, Med Devices)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-07	Common Stock	S	9735.0000	$116.0300	Disposed	43630.3956	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	96.0000	Indirect